• Title/Summary/Keyword: Platelet anti-aggregatory activities

Search Result 7, Processing Time 0.022 seconds

Synthesis of Substituted Cinnamoyl-tyramine Derivatives and their platelet Anti-aggregatory Activities

  • Woo, Nam-Tae;Jin, Sun-Yong;Cho, Jin-Cho;Kim, Nam-Sun;Bae, Bae-Eun-Hyung;Han, Ducky;Han, Byung-Hoon;Kang, Young-Hwa
    • Archives of Pharmacal Research
    • /
    • v.20 no.1
    • /
    • pp.80-84
    • /
    • 1997
  • Substituted cinnamoyl-tyramine derivatives were synthesized by DCC-coupling of substituted cinnamic acid with tyramine or tyramine methyl-1-ether to evaluate PAF-receptor binding antagonistic activities and inhibitory activities on PAF-induced platelet aggregation with interest on structure-activity relations. The results show that 3,4-dimethoxy-cinnamoyl tyramine-amide or its methyl ether have significant PAF-receptor binding antagonistic activity and platelet anti-aggregatory activities.

  • PDF

Platelet Anti-aggregating and Anti-oxidative Activities of 12-O-(4'-O-methyl-galloyl)-bergenin, a Novel Compound Isolated from Crassula cv. "Himaturi"

  • Lee, Yong-Yook;Jang, Dae-Song;Jin, Jing-Ling;YunChoi, Hye-Sook
    • Proceedings of the PSK Conference
    • /
    • 2003.10b
    • /
    • pp.193.3-194
    • /
    • 2003
  • Platelets play critical roles in both hemostasis and thrombosis. It was reported that platelet aggregation is associated with an increase in superoxide production and can be inhibited by hydroxyl radical scavengers. In the course of our search for the anti-platelet, anti-coagulant and/or anti-oxidative components from plants, the MeOH extract of Crassula cv. "Himaturi" (Crassulaceae) was observed to have both anti-aggregatory and anti-coagulant effects. A novel compound, 12-O-(4'-O-methyl-galloyl)-bergenin (1), was isolated as an active component from the EtOAC soluble fraction. (omitted)

  • PDF

Platelet Anti-Aggregating Plant Materials

  • YunChoi, Hye-Sook;Kim, Jae-Hoon;Kim, Sun-Ok;Lee, Jong-Ran
    • Korean Journal of Pharmacognosy
    • /
    • v.17 no.2
    • /
    • pp.161-167
    • /
    • 1986
  • The smear method developed by Velaskar and Chitre was modified to allow the screening of plant extracts and/or fractions for platelet anti-aggregating activity. The modified smear method was also found suitable for massive screening of pure compounds. Sample fractions prepared from various plant extracts were examined for their effects against ADP, arachidonic acid (AA) or collagen induced platelet aggregations. Several solvent fractions of plant extracts including water fraction prepared from the methanol extract of Acanthopanax sp. was inhibitory against rat platelet aggregations. The activity guided treatments and fractionations of the water fraction from A. senticosus Max yielded two anti-platelet aggregatory substances, 3, 4-dihydroxybenzoic acid (I) and its artefact ethyl 3, 4-dihydroxybenzoate(II). The inhibitory activities of I and II against rat platelet aggregation were compared with that of aspirin, a known inhibitor of platelet aggregation. Discussions also included the results of the investigations on the structural activity relationships among the various dihydroxybenzoic acid derivatives against platelet aggregations induced by either one of ADP, AA or collagen.

  • PDF

Study on Anti-thrombotic Activities of KIOM2003-080 (KIOM2003-080 처방에 대한 항혈전 효능 연구)

  • Jeon, Won-Kyung;Kim, Ho-Kyoung;Lee, Ju-Hyun;Ko, Byoung-Seob;Lee, A-Yeong;Lee, Kyung-Goo;Shin, Hyeun-Kyoo
    • Korean Journal of Oriental Medicine
    • /
    • v.13 no.2 s.20
    • /
    • pp.143-148
    • /
    • 2007
  • The present study examined inhibitory effects of 20 efficient experience prescriptions on platelet aggregation induced by collagen in human whole blood using the impedance method of aggregometry. Among them, a hot water extract of KIOM 2003-080 was selected to be the most effective candidate. In an in vivo study using a mouse acute thrombosis model, the anti-thrombotic effects of the KIOM2003-080 crude extract were also observed. In addition, we accessed bio-marker of platelet activation using thromboxane B2 by ELISA assay. A significantly decrease in thromboxane B2 production was seen in the presence of KIOM2003-080. Consequently, the results from this experiment provide pharmacological evidence for the traditional use of KIOM2003-080 prescription, suggesting that its hot water extracts could be used to prevent platelet aggregation and thrombosis disease.

  • PDF